Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Current assets
Cash	$ 419,163	$ 176,421
Accounts receivable, net of allowance for bad debt of $40,865 and $0	1,330,139	1,022,500
Royalty receivable	50,250	0
Inventory, net of allowance for obsolescence of $81,196 and $484	394,585	465,315
Prepaid other - related party	144,587	0
Prepaid and other assets	855,691	26,445
Total current assets	3,194,415	1,690,681
Long-term assets
Property, plant and equipment, net of accumulated depreciation of $74,403 and $511	72,422	18,777
Right of use assets - operating leases	193,634	0
Intangible assets, net of accumulated amortization of $532,535 and $0	19,754	0
Total long-term assets	285,810	18,777
Total assets	3,480,225	1,709,458
Current liabilities
Accounts payable	185,241	156,727
Accounts payable - related party	143,510	36,203
Accrued royalties and payables	412,435	228,606
Accrued bonus and commissions	1,057,050	701,125
Operating lease liability - current	98,071	0
Line of credit	1,000,000	0
Total current liabilities	2,896,307	1,122,661
Long-term liabilities
Operating lease liability - long term	106,580	0
Convertible notes payable - related party	1,500,000	0
Accrued interest	64,208	0
Total long-term liabilities	1,670,788	0
Total liabilities	4,567,095	1,122,661
Shareholders' equity (deficit)
Series F Convertible Preferred Stock: $10 par value, 1,200,000 shares authorized; 1,136,815 issued and outstanding as of June 30, 2019 and 1,136,815 issued and outstanding as of December 31, 2018	11,368,150	11,368,150
Common Stock: $0.001 par value, 20,000,000 shares authorized; 2,366,181 issued and outstanding as of June 30, 2019 and none issued and outstanding as of December 31, 2018	2,366	0
Additional Paid-in Capital	(12,080,629)	(10,919,639)
Retained earnings (accumulated deficit)	(375,703)	138,286
Total Sanara MedTech shareholders' equity (deficit)	(1,085,816)	586,797
Equity attributable to noncontrolling interest	(1,054)	0
Total shareholders' equity	(1,086,870)	586,797
Total liabilities and shareholders' equity	$ 3,480,225	$ 1,709,458